Iron Absorption From a Wheat-based Instant Cereal:Gut and Stable Isotope Studies in Kenyan Infants
1 other identifier
interventional
195
1 country
1
Brief Summary
The aim of this study is to measure the effect of a prebiotic (high dose/low dose) mixture at different doses within a wheat-based instant cereal, on fractional iron absorption (FIA), gut microbiota and inflammation after three weeks. FIA will be compared with and without three weeks of pre-feeding with two different doses of the prebiotic mixture.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 7, 2019
CompletedFirst Posted
Study publicly available on registry
March 28, 2019
CompletedStudy Start
First participant enrolled
July 23, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 4, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 4, 2020
CompletedMay 12, 2020
May 1, 2020
6 months
March 7, 2019
May 11, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
Fractional iron absorption (%)
Fractional iron absorption (erythrocyte incorporation of stable iron isotopes after 14 days of meal) from the wheat-based instant cereal containing FeFum and AA, with and without a prebiotic mixture after single dosing
Day 18
Fractional iron absorption (%)
Fractional iron absorption (erythrocyte incorporation of stable iron isotopes after 14 days of meal) from the wheat-based instant cereal containing FeFum and AA, with and without a prebiotic mixture after long-term dosing
Day 57
Secondary Outcomes (12)
Change in fecal Bifidobacteria abundance
Day 18 and day 39
Plasma ferritin
Baseline, Day 18, Day 39, Day 57
Soluble transferrin receptor
Baseline, Day 18, Day 39, Day 57
C-reactive protein
Baseline, Day 18, Day 39, Day 57
Alpha-1-acid glycoprotein
Baseline, Day 18, Day 39, Day 57
- +7 more secondary outcomes
Study Arms (3)
FeFum and 7.5 g prebiotic mixture
ACTIVE COMPARATORIntervention will be 3.6 mg Fe as Ferrous Fumarate and 7.5 g of prebiotic (high dose/low dose) mixture
FeFum and 3 g prebiotic mixture
ACTIVE COMPARATORIntervention will be 3.6 mg Fe as Ferrous Fumarate and 3 g of prebiotic (high dose/low dose) mixture
FeFum and no prebiotic mixture
ACTIVE COMPARATORIntervention will be 3.6 mg Fe as Ferrous Fumarate
Interventions
The 3 weeks intervention will consist of 24 g of wheat-based instant cereal and 90 ml of water per portion and will contain 3.6 mg FeFum and AA (molar ratio Fe:AA between 2.5 and 3) plus 7.5 g prebiotics mixture The absorption study test meals will consist of 24 g wheat-based instant cereal and 90 ml of water per portion and additionally: Test meal 1 will be composed of: 3.6 mg of Fe as 57FeFum and 0 g prebiotic mixture added extrinsically. Test meal 2 will be composed of: 3.6 mg of Fe as 1.5 mg iron as 58FeFum, 2.09 mg iron as 56FeFum and 7.5 g prebiotic mixture added extrinsically.
Standard wheat-based instant cereal containing 3.6 mg FeFum and AA (molar ratio Fe:AA between 2.5 and 3) plus 3 g prebiotics mixture per portion
Standard wheat-based instant cereal containing 3.6 mg FeFum and AA (molar ratio Fe:AA between 2.5 and 3) per portion.
Eligibility Criteria
You may qualify if:
- to 11 months at baseline
- Anticipated residence in study area for the study duration
- In good health as assessed by professional staff at Msambweni County Referral hospital
- Caregiver is willing to participate and able to comply with study procedures
- Informed consent form has been read and signed by the caregiver (or has been read out to the caregiver)
You may not qualify if:
- Hemoglobin concentration less than 70 g/L
- Severe underweight (Z-score weight-for-age \<-3)
- Severe wasting (Z-score weight-for-height \<-3
- Chronic or acute illness or other conditions that in the opinion of the Principal Investigator (PI) or study pediatrician would jeopardize the safety or rights of a participant in the trial or would render the participant unable to comply with the protocol
- Participant taking part in other studies requiring the drawing of blood
- Regular intake (\>2 days) of iron-containing mineral and vitamin supplements or fortified foods within the last 2 months
- Antibiotic treatment in the past 4 weeks prior to study enrollment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Swiss Federal Institute of Technologylead
- Danone Nutricia Researchcollaborator
Study Sites (1)
Msambweni County Referral Hospital
Msambweni, Kwale County, Kenya
Related Publications (2)
Mikulic N, Uyoga MA, Stoffel NU, Derrien M, Nyilima S, Kostopoulos I, Roeselers G, Chenoll E, Mwasi E, Pironaci G, Karanja S, Bourdet-Sicard R, Zimmermann MB. Prebiotics increase iron absorption and reduce the adverse effects of iron on the gut microbiome and inflammation: a randomized controlled trial using iron stable isotopes in Kenyan infants. Am J Clin Nutr. 2024 Feb;119(2):456-469. doi: 10.1016/j.ajcnut.2023.11.018. Epub 2023 Nov 30.
PMID: 38042412DERIVEDDerrien M, Mikulic N, Uyoga MA, Chenoll E, Climent E, Howard-Varona A, Nyilima S, Stoffel NU, Karanja S, Kottler R, Stahl B, Zimmermann MB, Bourdet-Sicard R. Gut microbiome function and composition in infants from rural Kenya and association with human milk oligosaccharides. Gut Microbes. 2023 Jan-Dec;15(1):2178793. doi: 10.1080/19490976.2023.2178793.
PMID: 36794816DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
March 7, 2019
First Posted
March 28, 2019
Study Start
July 23, 2019
Primary Completion
January 4, 2020
Study Completion
January 4, 2020
Last Updated
May 12, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share